Answers are grounded in this paper and cite their sources.
BACKGROUND: The Committee on Safety of Medicines (CSM) and National Institute for Health and Clinical Excellence have issued guidance on antidepressant use in depression in young people. METHOD: An anonymous survey was sent to 692 UK consultants in child and adolescent psychiatry; the response rate was 70.1%. RESULTS: Almost all (95.1%) respondents said fluoxetine was their antidepressant of first choice (29.9% only prescribed fluoxetine), although use of sertraline and citalopram was common. The CSM advice had resulted in 68.4% switching to fluoxetine only, or mostly. CONCLUSIONS: Clinicians appear to be adhering national guidance. Guidance needs to be regularly updated to reflect current evidence.
No takes yet. Share an insight, caveat, or question.
Haw et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: